| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5921293 | Cardiovascular Revascularization Medicine | 2014 | 5 Pages |
Abstract
The ORBIT I trial suggests that OAS treatment may offer an effective method to modify calcified coronary lesion compliance to facilitate optimal stent placement in these difficult-to-treat patients with acceptable levels of safety up to 3Â years post-index procedure.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
Authors
Parloop Bhatt, Parth Parikh, Apurva Patel, Milan Chag, Anish Chandarana, Roosha Parikh, Keyur Parikh,